CureGN: Understanding and Improving Care for Glomerular Diseases
Official title: The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
Funded at Columbia University Health Sciences · NIH-11577755 · Data updated 2026-11-12
A large, ongoing study follows adults and children with glomerular diseases to learn how these conditions progress and respond to treatment, with the goal of informing better care.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 16, 2013 |
| Project end | May 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $42,204 |
| NIH project number | 3U01DK100876-14S2 |
| Project ID | NIH-11577755 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults and children with Berger’s disease and related glomerular disorders (MCD, FSGS, IgAN, MN) who are enrolled in CureGN or eligible for participation across participating sites.
✕Less likely to help
Patients not fitting the study’s disease criteria or not enrolled in CureGN may not directly benefit.
What this research studies
CureGN is a long-term, observational effort that collects patient data, biospecimens, and patient-reported outcomes from diverse sites to understand diseases like MCD, FSGS, IgAN, and MN. Researchers use this rich resource to study how these conditions evolve over time and how therapies affect outcomes, aiming to translate findings into personalized care. Participants may have follow-up visits and provide samples, with results shared to improve treatment decisions for current and future patients. The network emphasizes collaboration among scientists, clinicians, and patient groups to accelerate discovery in glomerular disease.
Why it matters
Potential benefit: If successful, the study could lead to more precise and effective treatments tailored to individual patients.
How similar studies have gone: Previous CureGN efforts have recruited thousands of participants and generated valuable data for understanding glomerular diseases, though ongoing analyses continue to refine insights.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Bomback, Andrew Stephen — Columbia University Health Sciences
- Study coordinator: Bomback, Andrew Stephen
Related research
Other NIH-funded projects on the same topics.
-
Precision phenotyping of emphysema in the elderly: a study in diverse adults
Researchers will look at CT scans and lung tests in older adults to understand different forms of emphysema and how they relate to health outcomes.
-
HPV-based cervical cancer screening and treatment implementation in resource-limited settings
A collaborative project to help doctors in South Africa put HPV-based screening and same-day treatment for cervical cancer into routine care, so more people get fast, effective care.
-
Cervical cancer screening and treatment rollout in resource-poor settings
A team from Columbia and the University of Cape Town is testing how to best implement affordable, same-day HPV-based screen-and-treat for cervical cancer in public health settings.
-
Understanding SCN3A-related Developmental Epileptic Encephalopathy and Finding Better Treatments
This NIH grant focuses on how SCN3A gene variants cause developmental epileptic encephalopathy and aims to develop more effective therapies for affected patients.
-
mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support
A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.
-
M-CaRE: Mobile clinics and a smart heart-lung care tool for multimorbidity
A mobile, multilingual tool plus community health workers will help screen and manage high blood pressure and COPD in diverse adult patients, especially in underserved areas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.